Cosmetic Surgery Market Size, Share, Trends, Industry Analysis Report: By Procedure (Invasive and Non-invasive), Equipment, Gender, Age Group, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025 - 2034
The cosmetic surgery market size is expected to reach USD 567.70 billion by 2034, according to a new study by Polaris Market Research. The report “Cosmetic Surgery Market Size, Share, Trends, Industry Analysis Report: By Procedure (Invasive and Non-invasive), Gender, Age Group, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Cosmetic surgery involves procedures aimed at enhancing or reshaping a person's physical appearance. These include body contouring, wrinkle reduction, hair restoration, and breast augmentation. Both men and women seek cosmetic surgery to achieve aesthetic goals, boost self-confidence, and improve overall satisfaction with their appearance. The growth of the cosmetic surgery market is significantly increased by the rise of medical tourism, where patients travel either domestically or internationally to undergo medical procedures. For instance, in 2022, the Medical Tourism Index (MTI) ranked Canada as the top destination for medical tourism. Canada offers procedures at costs 30–60% lower than those in the US, attracting over 14 million Americans annually.
Facelifts and liposuction surgeries were among the cosmetic surgeries that were performed the most. Many countries offer medical tourism packages, with cost considerations being a primary driver. Compared to the United States, numerous regions provide identical procedures at substantially lower prices. Thus, the expansion of medical tourism is propelling the growth of the cosmetic surgery market.
The demand for cosmetic surgeries and minimally invasive procedures, such as botulinum toxin injections and facial fillers, has surged dramatically over the past decade, reflecting a significant shift in consumer preferences toward aesthetic enhancement. In recent years, U.S. consumers have consistently increased their expenditure on cosmetic procedures, underscoring the growing prioritization of aesthetic treatments. For instance, in August 2022, Revance announced the launch of RHA (resilient hyaluronic acid) collection fillers. The durable hyaluronic acid fillers are engineered to accommodate facial movements and serve as the initial offering in a series of products tailored for aesthetic procedures. Such, technological advancements in medical devices of the cosmetic surgery market are anticipated to drive growth over the forecast period.
Cosmetic Surgery Market Report Highlights
The 30–54 age group segment is anticipated to experience substantial growth with a significant CAGR in the global market due to its growing use of minimally invasive procedures.
The female segment accounted for the largest revenue share of the market in 2023 due to rising interest in cosmetic procedures among women, encompassing skin resurfacing and tightening, hair removal, breast augmentation, breast reduction, and various other treatments.In 2023, North America dominated the global cosmetic surgery market due to the skilled and certified cosmetic surgeons and the advanced healthcare infrastructure in the region.
The cosmetic surgery market in Japan is projected for substantial growth because of celebrity emulation, career advancement, and the influence of social media on Japanese patients.
The global key market players are Abbvie Incorportaipn; Alma Lasers Ltd.; Bausch Health Companies Inc.; Cynosure inc.; Galderma SA; HansBiomed Co., Ltd.; Mentor Worldwide LLC; Merz Pharma GmbH and Co.; Polytech Health & Aesthetics GmbH; Sientra Inc; Suneva Medical, Inc.; Sinclair Pharmaceuticals Limited; Revance Therapeutics, Inc.; and Teoxane Laboratories.
Polaris Market Research has segmented the cosmetic surgery market report based on procedure, gender, age group, and region:
By Procedure Outlook (USD Billion, 2020–2034)
Invasive
Non-invasive
By Gender Outlook (USD Billion, 2020–2034)
Male
Female
By Age Group Outlook (USD Billion, 2020–2034)
13–29
30–54
55 and above
By Regional Outlook (USD Billion, 2020–2034)
North America
Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America